MedPath

A study of potentially curative local therapy alone, or preceded by chemotherapy, in the treatment of Stage Ib-IVa cervical carcinoma

Completed
Conditions
Cervical cancer
Cancer
Registration Number
ISRCTN79554459
Lead Sponsor
Medical Research Council (MRC) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
313
Inclusion Criteria

1. Histologically proven invasive cancer of the cervix Stage Ib through to IVa
2. Patients must be fit enough to receive adjuvant chemotherapy, and the chosen definitive treatment
3. World Health Organisation (WHO) performance status zero to one or creatinine clearance of at least 60 ml/min
4. The informed consent of the patient

Exclusion Criteria

1. Previous chemotherapy
2. Renal, hepatic or bone marrow dysfunction which in the opinion of the investigator is sufficient to prejudice therapy (including local treatment and chemotherapy
3. Previous malignancy other than basal cell carcinoma
4. Medical or psychological conditions precluding treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath